These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
719 related articles for article (PubMed ID: 24310455)
21. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217 [TBL] [Abstract][Full Text] [Related]
22. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Sombekke MH; Wattjes MP; Balk LJ; Nielsen JM; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F Neurology; 2013 Jan; 80(1):69-75. PubMed ID: 23243070 [TBL] [Abstract][Full Text] [Related]
24. [Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature]. Sierra-Marcos A; Mitjana R; Castilló J; Edo MC; Horga-Hernández A; Tintoré M; Río-Izquierdo J; Auger-Acosta C; Rovira A; Montalban X Rev Neurol; 2010 Aug; 51(3):129-34. PubMed ID: 20645263 [TBL] [Abstract][Full Text] [Related]
25. The role of MRI in the diagnosis of multiple sclerosis. Traboulsee AL; Li DK Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event. Gout O; Bouchareine A; Moulignier A; Deschamps R; Papeix C; Gorochov G; Héran F; Bastuji-Garin S Mult Scler; 2011 Feb; 17(2):164-72. PubMed ID: 20965960 [TBL] [Abstract][Full Text] [Related]
27. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases]. Pou Serradell A; Roquer González J; Perich Alsina X Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729 [TBL] [Abstract][Full Text] [Related]
28. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658 [TBL] [Abstract][Full Text] [Related]
29. T2 hypointense rims and ring-enhancing lesions in MS. Llufriu S; Pujol T; Blanco Y; Hankiewicz K; Squarcia M; Berenguer J; Villoslada P; Graus F; Saiz A Mult Scler; 2010 Nov; 16(11):1317-25. PubMed ID: 20685762 [TBL] [Abstract][Full Text] [Related]
30. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology. Kobayashi M; Shimizu Y; Shibata N; Uchiyama S J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274 [TBL] [Abstract][Full Text] [Related]
31. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual. Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422 [TBL] [Abstract][Full Text] [Related]
32. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721 [TBL] [Abstract][Full Text] [Related]
33. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis. Sbardella E; Tomassini V; Stromillo ML; Filippini N; Battaglini M; Ruggieri S; Ausili Cefaro L; Raz E; Gasperini C; Sormani MP; Pantano P; Pozzilli C; De Stefano N Mult Scler; 2011 Dec; 17(12):1432-40. PubMed ID: 21729978 [TBL] [Abstract][Full Text] [Related]
35. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Atzori M; Battistella PA; Perini P; Calabrese M; Fontanin M; Laverda AM; Suppiej A; Drigo P; Grossi P; Rinaldi L; Gallo P Mult Scler; 2009 Mar; 15(3):363-70. PubMed ID: 18987105 [TBL] [Abstract][Full Text] [Related]
36. [Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions]. Navarro S; Mondéjar-Marín B; Pedrosa-Guerrero A; Pérez-Molina I; Garrido-Robres JA; Alvarez-Tejerina A Rev Neurol; 2005 Nov 16-30; 41(10):601-3. PubMed ID: 16288423 [TBL] [Abstract][Full Text] [Related]
37. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis. Chowdhury SA; Lin J; Sadiq SA Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193 [TBL] [Abstract][Full Text] [Related]
38. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI. Marques IB; Matias F; Silva ED; Cunha L; Sousa L J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563 [TBL] [Abstract][Full Text] [Related]
39. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations. Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950 [TBL] [Abstract][Full Text] [Related]
40. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases. Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]